Alaunos Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
Alaunos Therapeutics, Inc. (TCRT) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 214.95 million shares for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-16.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-05-16
- Alaunos Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-03-31 was 214.95M shares, a 0.46% increase year-over-year.
- Alaunos Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 214.67M shares, a 0.76% increase year-over-year.
- Alaunos Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 214.54M shares, a 0.80% increase year-over-year.
- Alaunos Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 214.43M shares, a 0.77% increase year-over-year.
- Alaunos Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 214.40M shares, a 2.27% increase from fiscal 2020.
- Alaunos Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 209.64M shares.
- Alaunos Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2017 was 136.94M shares, a 5.02% increase from fiscal 2016.
- Alaunos Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2016 was 130.39M shares, a 3.97% increase from fiscal 2015.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | 214.95M shares 10-Q · filed 2022-05-16 | 214.81M shares derived: average of 2 quarters · filed 2022-05-16 | 214.72M shares derived: average of 3 quarters · filed 2022-05-16 | 214.65M shares derived: average of 4 quarters · filed 2022-05-16 |
| 2021-12-31 | 214.67M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | 214.60M shares derived: average of 2 quarters · filed 2022-03-30 | 214.54M shares derived: average of 3 quarters · filed 2022-03-30 | 214.40M shares 10-K · filed 2022-03-30 |
| 2021-09-30 | 214.54M shares 10-Q · filed 2021-11-08 | 214.48M shares derived: average of 2 quarters · filed 2021-11-08 | 214.31M shares 10-Q · filed 2021-11-08 | 213.99M shares derived: average of 4 quarters · filed 2022-05-16 |
| 2021-06-30 | 214.43M shares 10-Q · filed 2021-08-13 | 214.19M shares 10-Q · filed 2021-08-13 | 213.81M shares derived: average of 3 quarters · filed 2022-05-16 | 213.57M shares derived: average of 4 quarters · filed 2022-05-16 |
| 2021-03-31 | 213.95M shares 10-Q · filed 2022-05-16 | 213.50M shares derived: average of 2 quarters · filed 2022-05-16 | 213.28M shares derived: average of 3 quarters · filed 2022-05-16 | 213.16M shares derived: average of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | 213.05M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | 212.95M shares derived: average of 2 quarters · filed 2022-03-30 | 212.89M shares derived: average of 3 quarters · filed 2022-03-30 | 209.64M shares 10-K · filed 2022-03-30 |
| 2020-09-30 | 212.84M shares 10-Q · filed 2021-11-08 | 212.81M shares derived: average of 2 quarters · filed 2021-11-08 | 208.50M shares 10-Q · filed 2021-11-08 | |
| 2020-06-30 | 212.79M shares 10-Q · filed 2021-08-13 | 206.30M shares 10-Q · filed 2021-08-13 | ||
| 2020-03-31 | 199.81M shares 10-Q · filed 2021-05-06 | |||
| 2019-09-30 | 170.61M shares 10-Q · filed 2020-11-05 | 165.70M shares derived: average of 2 quarters · filed 2020-11-05 | 164.05M shares 10-Q · filed 2020-11-05 | |
| 2019-06-30 | 160.79M shares 10-Q · filed 2020-08-06 | 160.72M shares 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | 160.64M shares 10-Q · filed 2020-05-07 | |||
| 2018-09-30 | 141.19M shares 10-Q · filed 2019-11-07 | 141.10M shares derived: average of 2 quarters · filed 2019-11-07 | 141.02M shares 10-Q · filed 2019-11-07 | 140.94M shares derived: average of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | 141.02M shares 10-Q · filed 2019-08-08 | 140.94M shares 10-Q · filed 2019-08-08 | 140.85M shares derived: average of 3 quarters · filed 2019-08-08 | 140.80M shares derived: average of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | 140.85M shares 10-Q · filed 2019-05-08 | 140.77M shares derived: average of 2 quarters · filed 2019-05-08 | 140.72M shares derived: average of 3 quarters · filed 2019-05-08 | 139.45M shares derived: average of 4 quarters · filed 2019-05-08 |
| 2017-12-31 | 140.68M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | 140.66M shares derived: average of 2 quarters · filed 2018-11-09 | 138.98M shares derived: average of 3 quarters · filed 2018-11-09 | 136.94M shares 10-K · filed 2018-03-01 |
| 2017-09-30 | 140.63M shares 10-Q · filed 2018-11-09 | 138.13M shares derived: average of 2 quarters · filed 2018-11-09 | 135.69M shares 10-Q · filed 2018-11-09 | 134.37M shares derived: average of 4 quarters · filed 2018-11-09 |
| 2017-06-30 | 135.63M shares 10-Q · filed 2018-08-08 | 133.18M shares 10-Q · filed 2018-08-08 | 132.28M shares derived: average of 3 quarters · filed 2018-08-08 | 131.84M shares derived: average of 4 quarters · filed 2018-08-08 |
| 2017-03-31 | 130.70M shares 10-Q · filed 2018-05-10 | 130.61M shares derived: average of 2 quarters · filed 2018-05-10 | 130.57M shares derived: average of 3 quarters · filed 2018-05-10 | 130.53M shares derived: average of 4 quarters · filed 2018-05-10 |
| 2016-12-31 | 130.52M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | 130.51M shares derived: average of 2 quarters · filed 2018-03-01 | 130.47M shares derived: average of 3 quarters · filed 2018-03-01 | 130.39M shares 10-K · filed 2018-03-01 |
| 2016-09-30 | 130.50M shares 10-Q · filed 2017-11-06 | 130.44M shares derived: average of 2 quarters · filed 2017-11-06 | 130.35M shares 10-Q · filed 2017-11-06 | 130.24M shares derived: average of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | 130.39M shares 10-Q · filed 2017-07-31 | 130.27M shares 10-Q · filed 2017-07-31 | 130.16M shares derived: average of 3 quarters · filed 2018-03-01 | 130.05M shares derived: average of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | 130.16M shares 10-Q · filed 2017-05-01 | 130.04M shares derived: average of 2 quarters · filed 2018-03-01 | 129.94M shares derived: average of 3 quarters · filed 2018-03-01 | 129.56M shares derived: average of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | 129.93M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | 129.83M shares derived: average of 2 quarters · filed 2018-03-01 | 129.36M shares derived: average of 3 quarters · filed 2018-03-01 | 125.42M shares 10-K · filed 2018-03-01 |
| 2015-09-30 | 129.73M shares 10-Q · filed 2016-11-09 | 129.07M shares derived: average of 2 quarters · filed 2016-11-09 | 123.91M shares 10-Q · filed 2016-11-09 | 118.75M shares derived: average of 4 quarters · filed 2017-02-16 |
| 2015-06-30 | 128.41M shares 10-Q · filed 2016-08-09 | 120.95M shares 10-Q · filed 2016-08-09 | 115.09M shares derived: average of 3 quarters · filed 2017-02-16 | 111.42M shares derived: average of 4 quarters · filed 2017-02-16 |
| 2015-03-31 | 113.41M shares 10-Q · filed 2016-05-10 | 108.43M shares derived: average of 2 quarters · filed 2017-02-16 | 105.76M shares derived: average of 3 quarters · filed 2017-02-16 | 104.43M shares derived: average of 4 quarters · filed 2017-02-16 |
| 2014-12-31 | 103.44M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | 101.93M shares derived: average of 2 quarters · filed 2017-02-16 | 101.43M shares derived: average of 3 quarters · filed 2017-02-16 | 101.13M shares 10-K · filed 2017-02-16 |
| 2014-09-30 | 100.43M shares 10-Q · filed 2015-11-02 | 100.43M shares derived: average of 2 quarters · filed 2015-11-02 | 100.36M shares 10-Q · filed 2015-11-02 | 98.92M shares derived: average of 4 quarters · filed 2016-02-24 |
| 2014-06-30 | 100.42M shares 10-Q · filed 2015-08-10 | 100.33M shares 10-Q · filed 2015-08-10 | 98.42M shares derived: average of 3 quarters · filed 2016-02-24 | 94.61M shares derived: average of 4 quarters · filed 2016-02-24 |
| 2014-03-31 | 100.23M shares 10-Q · filed 2015-05-07 | 97.42M shares derived: average of 2 quarters · filed 2016-02-24 | 92.67M shares derived: average of 3 quarters · filed 2016-02-24 | 90.27M shares derived: average of 4 quarters · filed 2016-02-24 |
| 2013-12-31 | 94.62M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | 88.89M shares derived: average of 2 quarters · filed 2016-02-24 | 86.95M shares derived: average of 3 quarters · filed 2016-02-24 | 85.94M shares 10-K · filed 2016-02-24 |
| 2013-09-30 | 83.16M shares 10-Q · filed 2014-10-30 | 83.12M shares derived: average of 2 quarters · filed 2014-10-30 | 83.05M shares 10-Q · filed 2014-10-30 | 82.63M shares derived: average of 4 quarters · filed 2015-02-26 |
| 2013-06-30 | 83.08M shares 10-Q · filed 2014-08-07 | 82.99M shares 10-Q · filed 2014-08-07 | 82.45M shares derived: average of 3 quarters · filed 2015-02-26 | 81.51M shares derived: average of 4 quarters · filed 2015-02-26 |
| 2013-03-31 | 82.91M shares 10-Q · filed 2014-05-08 | 82.14M shares derived: average of 2 quarters · filed 2015-02-26 | 80.98M shares derived: average of 3 quarters · filed 2015-02-26 | 80.36M shares derived: average of 4 quarters · filed 2015-02-26 |
| 2012-12-31 | 81.37M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | 80.02M shares derived: average of 2 quarters · filed 2015-02-26 | 79.52M shares derived: average of 3 quarters · filed 2015-02-26 | 78.55M shares 10-K · filed 2015-02-26 |
| 2012-09-30 | 78.67M shares 10-Q · filed 2013-10-22 | 78.59M shares derived: average of 2 quarters · filed 2013-10-22 | 77.61M shares 10-Q · filed 2013-10-22 | |
| 2012-06-30 | 78.51M shares 10-Q · filed 2013-08-08 | 77.07M shares 10-Q · filed 2013-08-08 | ||
| 2012-03-31 | 75.62M shares 10-Q · filed 2013-05-07 | |||
| 2011-12-31 | 66.00M shares 10-K · filed 2014-03-03 | |||
| 2010-12-31 | 46.00M shares 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |